Galderma Buys ZO Skin Health for $1.5 Billion
Galderma will buy ZO Skin Health from Blackstone and the Obagi family for $1.5 billion, adding the physician-dispelled skincare brand to its dermatology portfolio.
Topic
Topic
Galderma will buy ZO Skin Health from Blackstone and the Obagi family for $1.5 billion, adding the physician-dispelled skincare brand to its dermatology portfolio.
Galderma, maker of Cetaphil, will acquire physician-dispensed skincare brand ZO Skin Health for $1.5 billion, deepening its push…
Galderma is acquiring ZO Skin Health for $1.5 billion, per NewBeauty, in one of the year's largest dermatology-channel deals and…
Irvine-based ZO Skin Health, the physician-dispensed skincare brand, has been acquired in a $1.5 billion deal — one of the larges…
Galderma will pay US$1.5 billion to acquire ZO Skin Health, framing the deal as an expansion of its dermatological skin-care port…
Galderma will acquire physician-dispensed skincare brand ZO Skin Health for $1.5 billion, WWD reported, deepening its reach into…
Galderma will buy ZO Skin Health from Blackstone and the Obagi family for $1.5 billion, in a deal that prices physician-dispensed…
Galderma will pay $1.5 billion to acquire ZO Skin Health, extending its dermatology portfolio from injectable aesthetics into phy…
Galderma's $1.5 billion bid for Zo Skin Health, first reported by Fierce Pharma, ranks among the year's largest bets on physician…
Galderma has agreed to acquire ZO Skin Health for $1.5 billion, per Dermatology Times. The deal reshapes the physician-dispensed…